Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) is now available.
Ab&B Bio-Tech CO., LTD. JS reported that shareholders at its second extraordinary general meeting of 2025, held both onsite in Taizhou and online, approved all resolutions by poll with full support from the votes cast. Investors endorsed the appointment of Li Jianjun as an independent non-executive director and the reappointment of Deloitte Touche Tohmatsu as the company’s auditor for 2025, reinforcing the board’s governance structure and continuity in external auditing oversight, with no opposition or abstentions recorded and procedures confirmed as compliant with PRC regulations and Hong Kong listing rules.
More about Ab&B Bio-Tech CO., LTD. JS Class H
Ab&B Bio-Tech CO., LTD. JS is a joint stock company established in the People’s Republic of China and listed in Hong Kong under stock code 2627. The company operates in the biotechnology and life sciences sector, with operations based in Taizhou’s Medical High-tech Zone in Jiangsu province, positioning it within China’s growing medical and biopharmaceutical industry cluster.
Average Trading Volume: 177,990
Technical Sentiment Signal: Strong Sell
See more data about 2627 stock on TipRanks’ Stock Analysis page.